JP2003081807A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003081807A5 JP2003081807A5 JP2001275903A JP2001275903A JP2003081807A5 JP 2003081807 A5 JP2003081807 A5 JP 2003081807A5 JP 2001275903 A JP2001275903 A JP 2001275903A JP 2001275903 A JP2001275903 A JP 2001275903A JP 2003081807 A5 JP2003081807 A5 JP 2003081807A5
- Authority
- JP
- Japan
- Prior art keywords
- calendula
- weight
- melanocytes
- essence
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000002752 Melanocytes Anatomy 0.000 description 46
- 240000001432 Calendula officinalis Species 0.000 description 39
- 210000001787 Dendrites Anatomy 0.000 description 36
- 230000002401 inhibitory effect Effects 0.000 description 35
- 239000000686 essence Substances 0.000 description 29
- 239000003112 inhibitor Substances 0.000 description 28
- 210000003491 Skin Anatomy 0.000 description 24
- 241000208838 Asteraceae Species 0.000 description 23
- 235000005881 Calendula officinalis Nutrition 0.000 description 17
- 206010014970 Ephelide Diseases 0.000 description 17
- 235000003880 Calendula Nutrition 0.000 description 16
- 230000000694 effects Effects 0.000 description 14
- 206010061218 Inflammation Diseases 0.000 description 13
- 210000002540 Macrophages Anatomy 0.000 description 13
- 239000000049 pigment Substances 0.000 description 13
- 230000004054 inflammatory process Effects 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- -1 acetonitrile Chemical compound 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- 239000006210 lotion Substances 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 7
- 239000002798 polar solvent Substances 0.000 description 7
- 206010062080 Pigmentation disease Diseases 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 235000019437 butane-1,3-diol Nutrition 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N butylene glycol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000001629 suppression Effects 0.000 description 5
- LXCFILQKKLGQFO-UHFFFAOYSA-N Methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 4
- 230000002829 reduced Effects 0.000 description 4
- 210000002615 Epidermis Anatomy 0.000 description 3
- 241000272184 Falconiformes Species 0.000 description 3
- 210000003371 Toes Anatomy 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000019612 pigmentation Effects 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N ARBUTIN Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 229960003957 Dexamethasone Drugs 0.000 description 2
- UREBDLICKHMUKA-CXSFZGCWSA-N Dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N Indometacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N Oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- OIGNJSKKLXVSLS-VWUMJDOOSA-N Prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N Squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K Trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 229940099259 Vaseline Drugs 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 210000004027 cells Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000000875 corresponding Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N methylene dichloride Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 229960005205 prednisolone Drugs 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000001737 promoting Effects 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000011778 trisodium citrate Substances 0.000 description 2
- 229960001322 trypsin Drugs 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N 1,4-Benzenediol Natural products OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 1
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 1
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- GECRRQVLQHRVNH-MRCUWXFGSA-N 2-octyldodecyl (Z)-octadec-9-enoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC GECRRQVLQHRVNH-MRCUWXFGSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-L 2-sulfobutanedioate Chemical class OS(=O)(=O)C(C([O-])=O)CC([O-])=O ULUAUXLGCMPNKK-UHFFFAOYSA-L 0.000 description 1
- 210000000683 Abdominal Cavity Anatomy 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 229960000271 Arbutin Drugs 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N Cetyl alcohol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- JYGXADMDTFJGBT-VWUMJDOOSA-N Cortisol Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 1
- 210000004207 Dermis Anatomy 0.000 description 1
- 229960001193 Diclofenac Sodium Drugs 0.000 description 1
- 102000003425 EC 1.14.18.1 Human genes 0.000 description 1
- 108060008724 EC 1.14.18.1 Proteins 0.000 description 1
- 229960000905 Indomethacin Drugs 0.000 description 1
- 206010022114 Injury Diseases 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- 229940114937 MICROCRYSTALLINE WAX Drugs 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- TZIHFWKZFHZASV-UHFFFAOYSA-N Methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N Oleyl alcohol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229940066842 Petrolatum Drugs 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N Retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- JNYAEWCLZODPBN-CTQIIAAMSA-N Sorbitan Chemical compound OCC(O)C1OCC(O)[C@@H]1O JNYAEWCLZODPBN-CTQIIAAMSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N Stearyl alcohol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- 210000002784 Stomach Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 230000001668 ameliorated Effects 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000507 anthelmentic Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agents Drugs 0.000 description 1
- 230000000111 anti-oxidant Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000002026 carminative Effects 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 125000005131 dialkylammonium group Chemical group 0.000 description 1
- KPHWPUGNDIVLNH-UHFFFAOYSA-M diclofenac sodium Chemical compound [Na+].[O-]C(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl KPHWPUGNDIVLNH-UHFFFAOYSA-M 0.000 description 1
- 229940079593 drugs Drugs 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000001771 impaired Effects 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003287 optical Effects 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229920000406 phosphotungstic acid polymer Polymers 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 229920001888 polyacrylic acid Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002335 preservative Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 230000002195 synergetic Effects 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- 230000000699 topical Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000002087 whitening Effects 0.000 description 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001275903A JP2003081807A (ja) | 2001-09-12 | 2001-09-12 | メラノサイトのデンドライトの伸長抑制剤及びそれを含有する化粧料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001275903A JP2003081807A (ja) | 2001-09-12 | 2001-09-12 | メラノサイトのデンドライトの伸長抑制剤及びそれを含有する化粧料 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2003081807A JP2003081807A (ja) | 2003-03-19 |
JP2003081807A5 true JP2003081807A5 (fi) | 2008-10-16 |
Family
ID=19100687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001275903A Pending JP2003081807A (ja) | 2001-09-12 | 2001-09-12 | メラノサイトのデンドライトの伸長抑制剤及びそれを含有する化粧料 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2003081807A (fi) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100496452C (zh) | 2003-12-15 | 2009-06-10 | 可乐丽股份有限公司 | 皮肤外用剂 |
CN106038399B (zh) * | 2016-06-30 | 2018-11-13 | 山东师范大学 | 一种消炎防皲裂除臭的脚膜及其制备方法 |
KR102318369B1 (ko) * | 2019-11-15 | 2021-10-28 | 부산대학교 산학협력단 | 생체 적합 나노전달체를 포함하는 자외선 차단용 화장료 조성물 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60163810A (ja) * | 1984-02-06 | 1985-08-26 | Dr Kawai Kurinitsuku:Kk | 練り歯磨組成物 |
JPH11180854A (ja) * | 1997-12-24 | 1999-07-06 | Lion Corp | 皮膚外用剤 |
JP2000007546A (ja) * | 1998-06-18 | 2000-01-11 | Yakult Honsha Co Ltd | 色素沈着防止剤並びにこれを利用する皮膚化粧料および皮膚外用剤 |
JP2000302634A (ja) * | 1999-04-27 | 2000-10-31 | Ichimaru Pharcos Co Ltd | 化粧料組成物 |
JP4395221B2 (ja) * | 1999-08-18 | 2010-01-06 | 独立行政法人産業技術総合研究所 | 色素異常症の処置に有効な物質のスクリーニング法 |
JP2001199866A (ja) * | 2000-01-24 | 2001-07-24 | Pola Chem Ind Inc | メラノサイトのデンドライトの伸長抑制剤及びそれを含有する化粧料 |
JP4290841B2 (ja) * | 2000-01-24 | 2009-07-08 | ポーラ化成工業株式会社 | メラノサイトのデンドライトの伸長抑制剤及びそれを含有する化粧料 |
-
2001
- 2001-09-12 JP JP2001275903A patent/JP2003081807A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3499616B2 (ja) | ヒドロキシチロソール、メラニン生成抑制剤又は過酸化脂質生成抑制剤への応用 | |
JP2003081746A (ja) | メラノサイトのデンドライトの伸長抑制剤及びそれを含有する化粧料 | |
JP3709363B2 (ja) | メラノサイトのデンドライトの伸長抑制剤及びそれを含有する化粧料 | |
JP2003081746A5 (fi) | ||
JP4290841B2 (ja) | メラノサイトのデンドライトの伸長抑制剤及びそれを含有する化粧料 | |
JP2002154919A (ja) | メラノサイトのデンドライトの伸長抑制剤及びそれを含有する化粧料 | |
JP2003081747A5 (fi) | ||
JP2002154920A (ja) | メラノサイトのデンドライトの伸長抑制剤及びそれを含有する化粧料 | |
JP2003081807A5 (fi) | ||
JP2009057312A (ja) | 抗酸化剤および該抗酸化剤を含む化粧料 | |
JPH0672838A (ja) | 化粧料 | |
JP2001199866A (ja) | メラノサイトのデンドライトの伸長抑制剤及びそれを含有する化粧料 | |
JP4646364B2 (ja) | メラノサイトのデンドライトの伸長抑制剤及びそれを含有する化粧料 | |
JP2003081747A (ja) | メラノサイトのデンドライトの伸長抑制剤及びそれを含有する化粧料 | |
JP2003081807A (ja) | メラノサイトのデンドライトの伸長抑制剤及びそれを含有する化粧料 | |
KR20150132753A (ko) | 항산화 및 항균 효과를 가지는 상엽 초임계 추출물의 제조 방법 | |
JP6281761B2 (ja) | ヒダカミセバヤエキスを含有する外用剤又は内用剤 | |
JP4441083B2 (ja) | メラノサイトのデンドライトの伸長抑制剤及びそれを含有する化粧料 | |
JP3796190B2 (ja) | メラノサイトのデンドライト伸長抑制剤及びそれを含有してなる皮膚外用剤 | |
JP2003081748A (ja) | メラノサイトのデンドライトの伸長抑制剤及びそれを含有する化粧料 | |
JP6242575B2 (ja) | デンドライト伸長抑制剤 | |
JP5690149B2 (ja) | 外用剤又は内用剤 | |
JP2001335502A (ja) | メラノサイトのデンドライトの伸長抑制剤及びそれを含有する化粧料 | |
JP2004137166A (ja) | 皮膚外用剤、細胞賦活剤、抗酸化剤 | |
JP4473439B2 (ja) | 美白剤 |